|
Middle Eastern Countries Look to Decrease Pharmaceutical Imports
Eighty percent of drugs consumed in the Middle East are currently imported, but governments across the region are trying to change that by boosting domestic manufacturing and joint ventures and licensing deals, according to Frost & Sullivan’s analysis of the Gulf Cooperation Council (GCC) pharmaceutical market.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives